PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2849677-0	1988	Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine.	Pirenzepine	121-132	5'-nucleotidase, cytosolic II	Mus musculus	72-75	
2849677-1	1988	Pirenzepine selectively antagonized muscarinic receptor-mediated cyclic GMP formation in a noncompetitive fashion in mouse neuroblastoma cells (clone N1E-115).	Pirenzepine	0-11	5'-nucleotidase, cytosolic II	Mus musculus	72-75	
2849677-8	1988	Therefore, the noncompetitive antagonism by pirenzepine detected in cyclic GMP measurements might be only apparent and might be attributed, at least in part, to a lack of an equilibrium state under the specific conditions of these assays.	Pirenzepine	44-55	5'-nucleotidase, cytosolic II	Mus musculus	75-78	
2982089-4	1985	Pirenzepine inhibited the [3H]cyclic GMP response to carbachol with a KD value of approximately 6 nM, whereas it inhibited the ability of carbachol to reduce prostaglandin E1-mediated elevations in [3H]cyclic AMP levels with a KD value of 93 nM, thus differentiating between two classes of receptors involved in these responses.	Pirenzepine	0-11	5'-nucleotidase, cytosolic II	Mus musculus	37-40